A Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NSCLC Patients

Clinical trial NCT06335355 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06335355
Sponsor: Shanghai Shengdi Pharmaceutical Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Non-squamous Non-small Cell Lung Cancer

Start date: 2024-03-01
Primary completion: 2028-10-01
Enrollment: 401

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.